Biotech Stocks Continue Momentum in After-Hours Trading Despite Lack of Fresh News

Wednesday, Dec 17, 2025 11:29 pm ET1min read
ACB--
ELDN--
EUDA--
LXEO--
SLDB--

Several small- and mid-cap biotech stocks, including Spyre Therapeutics, The Oncology Institute, and Solid Biosciences, posted notable gains in after-hours trading despite no new company updates. The movement was driven by investor sentiment and sector momentum, with the biotech sector showing renewed strength. Other stocks, such as Aurora Cannabis and EUDA Health Holdings, also recorded gains without new news. Lexeo Therapeutics and Eledon Pharmaceuticals posted modest gains.

Biotech Stocks Continue Momentum in After-Hours Trading Despite Lack of Fresh News

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet